Patient-reported outcomes after treatment for rectal cancer-A prospective nationwide study.

ABSTRACT:

Aim

While modern treatment has improved rectal cancer (RC) survival, it can cause late side effects that impact health-related quality of life (HRQoL). The aim of this study was to evaluate HRQoL and late effects 1 year after diagnosis in patients who underwent major resection for Stage I-III RC.

Method

All patients with RC registered in the Cancer Registry of Norway between 1 January 2019 and 31 December 2020, aged ≥ 18 years, and a control group without colorectal cancer were invited to participate in the study by answering a questionnaire on HRQoL and late effects. Functional domains and symptoms were compared in different patient groups and between patients and controls.

Results

There were 558 patients and 1693 controls eligible for analysis. Response rates were 4

SUBMITTER: Slordahl KS 

PROVIDER: S-EPMC11683195 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature